JANEEN MANOUN: Open Payments
NPI 1609446467 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 65 payments from 25 companies in 2025. Trend: 2023 $1,246 · 2024 $1,160 · 2025 $1,333
Food & beverage: $1,333
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 9 | $160 |
| Novo Nordisk Inc | 7 | $145 |
| Dexcom, Inc. | 4 | $91 |
| Neurocrine BioSciences, Inc. | 3 | $76 |
| Mannkind Corporation | 4 | $73 |
| Corcept Therapeutics | 3 | $72 |
| BETA BIONICS, INC. | 3 | $71 |
| Tandem Diabetes Care, Inc. | 4 | $71 |
| Ascendis Pharma Endocrinology Inc | 3 | $71 |
| Lilly USA, LLC | 4 | $70 |
Products named: Dexcom G6 Transmitter, TEPEZZA, Wegovy, CRENESSITY, AFREZZA, Korlym, iLet Bionic Pancreas, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
